Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipyridamole for Ischemia-Reperfusion Injury Protection
NCT00457405Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2007
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dipyridamole in ischemia-reperfusion injury (IRI), sponsored by Radboud University Medical Center. Started Jun 2007; status: completed.
02
Drugs
dipyridamole
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT00457405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00457405.